High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism

Blood

Volumn 110, Issue 7, 2007, Pages 2235-2241

  Kawase, Takakazu ^a   Morishima, Yasuo ^a   Matsuo, Keitaro ^a   Kashiwase, Koichi ^b   Inoko, Hidetoshi ^c   Saji, Hiroh ^d   Kato, Shunichi ^c   Juji, Takeo ^e   Kodera, Yoshihisa ^f   Sasazuki, Takehiko ^g  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b Japanese Red Cross Tokyo Metropolitan Blood Center   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Japanese Red Cross Kanto Koshinetsu Block Blood Center   (Japan)

^e Research and Development Department   (Japan)

^f JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^g NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DPB1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SUBSTITUTION; CONFERENCE PAPER; FEMALE; GENE LOCUS; GRAFT VERSUS HOST REACTION; HISTOINCOMPATIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ACUTE DISEASE; ADULT; ALLELES; AMINO ACIDS; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; MALE; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; RISK FACTORS; SURVIVAL RATE;

EID: 34948865802     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-02-072405     Document Type: Conference Paper

References (34)

1. Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med. 1993;328:593-602.
2. Kodera Y, Morishima Y, Kato S, et al. Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia. Bone Marrow Transplant. 1999;24:995-1003.
3. Petersdorf EW, Gooley TA, Anasetti C, et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood. 1998;92:3515-3520.
4. Sasazuki T, Juji T, Morishima Y, et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor: Japan Marrow Donor Program. N Engl J Med. 1998;339:1177-1185.
5. Morishima Y, Sasazuki T, Inoko H, et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood. 2002;99:4200-4206.
6. Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood. 2004;104:1923-1930.
7. Petersdorf EW, Kollman C, Hurley CK, et al. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience. Blood. 2001;98:2922-2929.
8. Davies SM, Kollman C, Anasetti C, et al. Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program. Blood. 2000;96:4096-4102.
9. Morishima Y, Yabe T, Matsuo K, et al. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor. Biol Blood Marrow Transplant. 2007;13:315-328.
10. Zino E, Frumento G, Marktel S, et al. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood. 2004;103:1417-1424.
11. Fleischhauer K, Locatelli F, Zecca M, et al. Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction. Blood. 2006;107:2984-2992.
12. Allele Frequencies Database: USA Caucasian Bethesda, USA Olmstead County Minesota. Available at: http://www.allelefrequencies.net. Accessed May 1, 2007.
13. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15:825-828.
14. IMGT/HLA Sequence Database. Available at: http://www.ebi.ac.uk/imgt/hla/. Accessed February 1, 2007.
15. Socie G. Graft-versus-host disease-from the bench to the bedside? N Engl J Med. 2005;353:1396-1397.
16. Hansen JA, Gooley TA, Martin PJ, et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med. 1998;338:962-968.
17. Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982;157:105-132.
18. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695-706.
19. Coviello V, Boffess M. Cumulative incidence estimation in the presence of compiting risks. Stata J. 2004;4:103-112.
20. Cox DR. Regression models and life-tables. J R Stat Soc (B). 1972;34:187-220.
21. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373-1379.
22. Efron B. Bootstrap methods: another look at the jackknife. Ann Stat. 1979;7:1-26.
23. Manly BFJ. Randomization, Bootstrap and Monte Carlo Methods in Biology. London, United Kingdom: Chapman and Hall; 1997.
24. Macdonald WA, Purcell AW, Mifsud NA, et al. A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J Exp Med. 2003;198:679-691.
25. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol. 2005;5:201-214.
26. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 1987;329:506-512.
27. Petersdorf EW, Hansen JA, Martin PJ, et al. Major-histocompatibility- complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med. 2001;345:1794-1800.
28. Steven GE, Peter P, Linda DB. The HLA Facts Book. London, United Kingdom: Academic Press; 2000.
29. Ferrara GB, Bacigalupo A, Lamparelli T, et al. Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. Blood. 2001;98:3150-3155.
30. Hogan KT, Clayberger C, Bernhard EJ, et al. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3. J Immunol. 1988;141:2519-2525.
31. Mattson DH, Shimojo N, Cowan EP, et al. Differential effects of amino acid substitutions in the beta-sheet floor and alpha-2 helix of HLA-A2 on recognition by alloreactive viral peptide-specific cytotoxic T lymphocytes. J Immunol. 1989;143:1101-1107.
32. Shimojo N, Cowan EP, Engelhard VH, Maloy WL, Coligan JE, Biddison WE. A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73. J Immunol. 1989;143:558-564.
33. Tynan FE, Elhassen D, Purcell AW, et al. The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation. J Exp Med. 2005;202:1249-1260.
34. Biro JC. Amino acid size, charge, hydropathy indices and matrices for protein structure analysis. http://www.tbiomed.com/content/pdf/1742-4682-3-15. pdf. Accessed February 1, 2007.